The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTI1.L Regulatory News (TI1)

  • There is currently no data for TI1

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM - Replacement

15 Jun 2021 09:32

RNS Number : 9290B
Trian Investors 1 Limited
15 June 2021
 

 

 

15 June 2021

 

The following amendment has been made to the Results of AGM announcement released on 14 June 2021 at 15:21 under RNS No 8428B.

 

The number of for votes in respect of resolution 5 was 220,225,935. All other details remain unchanged.

 

TRIAN INVESTORS 1 LIMITED

RESULTS OF ANNUAL GENERAL MEETING

Trian Investors 1 Limited (the "Company") announces voting results from its annual general meeting ("AGM") held earlier today. Shareholders representing 98.2% of the Company's shares in issue (excluding shares held in treasury) voted on the resolutions. The Company's shareholders have approved all resolutions proposed at the AGM, as detailed in the Company's Circular posted on 17 May 2021, including the proposed amendments to the Company's investment policy. The Board and the Company's investment manager believe the revised investment policy will help position the Company to capitalise on a broader range of potential investment opportunities and to compound shareholders' capital over time by reinvesting investment profits.

 

 

Chris Sherwell, Chairman of the Company, said:

"My fellow directors, Mark Thompson and Simon Holden, and I greatly appreciate our recent discussions with shareholders. We believe that Trian Investors 1's revised investment policy should generate long-term shareholder value and make Trian Investors 1 a larger, more widely followed public company. At the same time, we acknowledge the feedback received from the Company's shareholders who voted against the revisions to the investment policy and we intend to engage promptly with them. We remain highly committed both to monitoring the Company's trading activity and to seeking to improve the liquidity and the gap between the trading price and net asset value (NAV) of the Company's shares. In addition, we believe the Company will have the capacity to complete additional share repurchases opportunistically, if warranted."

 

Nelson Peltz, Ed Garden and Peter W. May, the Founding Partners of Trian Fund Management, L.P., the parent of the Company's investment manager, Trian Investors Management, LLC (collectively, "Trian"), said:

"We have a high degree of conviction in Trian Investors 1's trajectory, especially in light of the revised Company policies and guidelines, which we believe will further its ability to compound profits for the benefit of shareholders. For these reasons, as we have previously said, we are planning to invest more of our own capital in the Company through the purchase of additional shares in the open market, subject to market conditions. In addition, in order to further align our interests with shareholders, we will receive future incentive allocations, net of certain tax liability amounts, in the form of shares, to be valued at NAV. We also were pleased to have the opportunity to speak to many of the Company's shareholders over the last few weeks and receive their feedback and we look forward to continuing that dialogue. We are excited to continue to work with the Board as we seek opportunities to create further value for the Company's shareholders."

 

Further Information

The voting breakdown of each of the resolutions is set forth on Annex A to this Announcement. Further information on the resolutions presented at the AGM are described in further detail in the Circular, which is available on the Company's website at https://www.trianinvestors1.com and also available on the national storage mechanism at https://www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism. The Circular sets out important information regarding the resolutions, and shareholders are strongly encouraged to read it in its entirety.

 

 

 

 

 

 

ANNEX A

Ordinary Resolutions

For

Against

Withheld*

1. To receive the Annual Report and Audited Financial Statementsof the Company for the year ended 31 December 2020 (the "Annual Report").

 

248,803,202

 

(100%)

 

 

0

 

(0%)

 

0

2. That the Directors' remuneration for the period ended December 2020 as provided in the Director's report contained in the Annual Report be approved.

 

248,803,202

 

(100%)

 

0

 

(0%)

 

0

3. To re-appoint Deloitte LLP as Auditor of the Company.

 

245,522,903

 

(98.70%)

 

3,280,299

 

(1.30%)

 

0

4. To authorise the Directors to determine the remuneration ofDeloitte LLP.

 

 

245,522,903

 

(98.70%)

 

3,280,299

 

(1.30%)

 

0

5. To re-appoint Chris Sherwell as a Director of the Company.

 

220,225,935

 

(90.23%)

 

23,900,968

 

(9.77%)

 

4,676,299

6. To re-appoint Mark Thompson as a Director of the Company.

 

224,902,234

 

(90.41%)

 

23,900,968

 

(9.59%)

 

0

7. To re-appoint Simon Holden as a Director of the Company.

 

224,902,234

 

(90.41%)

 

23,900,968

 

(9.59%)

 

0

8. To authorise the Company to make market acquisitions of its ordinary shares, or any different classes of shares, either for retention as treasury shares or cancellation.

 

248,803,202

 

(100%)

 

0

 

0%

 

0

9. To adopt the proposed changes to the investment policy of the Company.

 

119,769,130

 

(52.25%)

 

109,497,360

 

(47.75%)

 

19,536,712

 

*A vote withheld is not a vote in law and is therefore not counted in the calculation of the proportion of votes "For" or "Against" any resolution.

For enquiries, please contact:

 

Ocorian Administration (Guernsey) Limited

(Administrator and Company Secretary)

Ian Smith

 

+44 (0)1481 742 742

Greenbrook Communications Limited

(Communications Adviser)

Andrew Honnor / Rob White

 

+44 (0)20 7952 2000

trian@greenbrookpr.com

 

 

About the Company:

 

The Company is a Guernsey domiciled limited company, which was admitted to trading on the Specialist Fund Segment of the London Stock Exchange on 27 September 2018. Its investment objective is to generate significant capital appreciation through Trian's activity as a highly engaged shareowner. In accordance with its investment policy, the Company has made a substantial minority investment through its investment in Trian Investors 1, L.P., in the amount of approximately £250 million, in Ferguson plc.

 

Founded by Nelson Peltz, Ed Garden and Peter May, Trian seeks to invest in high quality but undervalued and underperforming public companies and to work collaboratively with management teams and boards of those companies to execute operational, strategic and environmental, social and governance (ESG) initiatives designed to drive long-term sustainable earnings growth for the benefit of all stakeholders. This investment strategy has been deployed by Trian's founders over a variety of market cycles for nearly five decades.

 

LEI number: 213800UQPHIQI5SPNG39

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGZZGMVRKDGMZG
Date   Source Headline
26th Apr 20234:22 pmRNSNotice of EGM Results
26th Apr 20234:21 pmRNSNotice of AGM Results
26th Apr 20237:30 amRNSSuspension - Trian Investors 1 Limited
17th Apr 20235:03 pmRNSNet Asset Value as at 31 March 2023
6th Apr 20232:55 pmRNSHolding(s) in Company
3rd Apr 20237:00 amRNSTotal Voting Rights
24th Mar 20237:01 amRNSNotice of EGM
24th Mar 20237:00 amRNSNotice of AGM
22nd Mar 20237:00 amRNSDirector/PDMR Shareholding
17th Mar 20237:00 amRNSAnnual Report to 31 December 2022
16th Mar 202312:08 pmRNSNAV as at 28 February 2023 and as at 13 March 2023
14th Mar 20232:43 pmRNSTotal Voting Rights
2nd Mar 20237:00 amRNSCompulsory Share Redemption Update
22nd Feb 20232:53 pmRNSNet Asset Value as at 16 February 2023
22nd Feb 20232:37 pmRNSNet Asset Value as at 31 January 2023
17th Feb 20237:00 amRNSCompulsory Share Redemption Update
1st Feb 20237:00 amRNSTotal Voting Rights
19th Jan 20237:00 amRNSNet Asset Value as at 6 January 2023
19th Jan 20237:00 amRNSIn-specie Distribution & Complusory Redemption
9th Jan 20236:01 pmRNSNet Asset Value as at 31 December 2022
9th Jan 20237:00 amRNSCompulsory Share Redemption Update
14th Dec 20225:26 pmRNSNet Asset Value as at 30 November 2022
11th Nov 20224:34 pmRNSNet Asset Value as at 31 October 2022
26th Oct 20225:16 pmRNSReplacement - Net Asset Value(s)
25th Oct 20224:16 pmRNSNet Asset Value as at 30 September 2022
24th Oct 20228:51 amRNSHolding(s) in Company
15th Sep 20227:00 amRNSInterim Results
14th Sep 20227:00 amRNSNet Asset Value as at 31 August 2022
6th Sep 202210:42 amRNSHolding(s) in Company
2nd Sep 20227:00 amRNSCompulsory Share Redemption by 30 June 2023
15th Aug 20225:30 pmRNSChanges to Director Roles and Responsibilities
12th Aug 20227:00 amRNSNet Asset Value as at 31 July 2022
8th Aug 20227:00 amRNSResult of EGM
8th Aug 20227:00 amRNSDirector Changes
8th Aug 20227:00 amRNSResult of AGM
11th Jul 20222:01 pmRNSNotice of AGM
11th Jul 20222:00 pmRNSNotice of Requisitioned EGM
11th Jul 20227:00 amRNSNet Asset Value as at 30 June 2022
1st Jul 20227:00 amRNSTotal Voting Rights
21st Jun 20227:00 amRNSTransaction in Own Shares
20th Jun 20223:56 pmRNSReceipt of Requisition Notice
15th Jun 20227:00 amRNSNet Asset Value as at 31 May 2022
31st May 20228:00 amRNSInvestment in Unilever
6th May 20226:00 pmRNSNet Asset Value as at 30 April 2022
14th Apr 20227:01 amRNSDirector Appointment
14th Apr 20227:00 amRNSAnnual Report to 31 December 2021
13th Apr 20225:53 pmRNSNet Asset Value as at 31 March 2022
29th Mar 202210:11 amRNSNew US$100m Revolving Credit Facility
16th Mar 20224:53 pmRNSNet Asset Value as at 28 February 2022
1st Mar 20227:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.